Enteric
spectomix

spectomix®

Spectinomycin 22%
Lincomycin 22%

The broad-spectrum solution against the complex of enteric diseases

SPECTOMIX® is a soluble powdered antimicrobial consisting of a combination of the active substances lincomycin and spectinomycin at a 1:1 ratio. The combination of such substances offers greater product activity by broadening the spectrum of action and the synergism between the two substances, making SPECTOMIX® an excellent tool for maintaining the intestinal health of poultry and swine. In addition to potent antimicrobial activity, SPECTOMIX® features:

Formulation adapted to the market necessities;
Excellent fluidity and miscibility;
Water stability;
Thermostable;
Label and methodology aligned with the most current market requirements;
Proven efficacy against Clostridium sp., E. coli, Salmonella spp. and Lawsonia intracellularis;
Dose flexibility.

FORMULA

Each 100 g of SPECTOMIX® contains:
Spectinomycin (as sulfate tetrahydrate)……………………………………..22.0 g
Lincomycin (as hydrochloride)…………………………………………………..22.0 g
Excipient q.s…………………………………………………………………………..100.0 g

INDICATION

This product is indicated to prevent and treat diseases caused by Escherichia coli, Salmonella spp, Clostridium perfringens and Lawsonia intracellularis.

DIRECTIONS FOR USE

Prophylactic Usage: The recommended prophylactic dose is 5 mg of the combination of active ingredients per kilogram live weight per day, for 21 consecutive days for poultry and 14 days for swine.
Therapeutic Usage: The recommended therapeutic dose is 10 mg of the combination of active ingredients per kilogram live weight per day, for 7 consecutive days for poultry and swine.

Presentation

200 g Sachet in box with 25 sachets;
25 kg Bag.

Withdrawal Period

Poultry: Withdraw the drug 4 days before slaughter.
Swine: Withdraw the drug 6 days before slaughter.

Compartilhar:

OTHER PRODUCTS FROM Entéricos:

Cookie Notice

By clicking on "Accept all cookies", you agree to the storage of cookies on your device to improve navigation, analyze website usage and contribute to our marketing and commercial initiatives.

Learn moreAccept all cookies